<DOC>
	<DOCNO>NCT02445924</DOCNO>
	<brief_summary>This study carry 40 subject Chest department Tanta university hospital The subject classify three group : - Group I : include ten non smoker volunteer ( control group I ) . - GroupII : include ten smoker volunteer ( control groupII ) . - Group III : include twenty NSCLC patient confirm pathological examination bronchoalveolar examination ( BAL ) , brush and/or biopsy .</brief_summary>
	<brief_title>Micro RNA Genetic Signature NSCLC Egyptian Patients</brief_title>
	<detailed_description>The patient control group subject follow : - Complete history take complete general examination . - Complete chest examination . - Radiological assessment include chest x ray ( posteroanterior lateral view ) . - Computed tomography ( CT ) chest patient group III need group I II . - Laboratory investigation : - Complete blood picture - Fasting post parandial blood sugar level - liver function test - kidney function test ( urea creatinine ) . - Prothrombine time activity . - Zeil-Neelsen staining sputum . - Tumour marker include Î± Fetoprotein , Carcino Embryonic antigen ( CEA ) , CA19-9 , CA 125 , CA15-3 others . - Venous blood sample collect peripheral blood ( 5 ml ) complete aseptic technique . Serum sample obtain centrifugation . Isolation total RNA serum pool perform . RNA profile quantification assess use Microarray . - Lung biopsy either transbronchial via bronchoscopy peripherally via ultrasound , CT guide , thoracoscopy open lung biopsy perform isolation total RNA lung tissue biopsy . RNA profile quantification assess use Microarray . - Bronchoalveolar lavage perform isolation total RNA . RNA profile assess use Microarray . Ethical consideration : 1 . Informed consent take subject 's include : A . The aim research . B . All data confidential . C. All data use research . 2 . For patient 's privacy : A . There code number patient special folder . B . The result research use scientific publishing . 3 . Unexpected risk appear course research clear participant ethical committee time .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<criteria>Inclusion criterion patient : Non small cell lung cancer patient recently diagnose receive chemotherapy , surgery radiation therapy . Exclusion criteria patient : Diagnosis asthma COPD . Broncheiactasis . upper/lower respiratory tract infection precede 4 week . Active pulmonary tuberculosis . Associated cancer beside lung cancer . Patients receive chemotherapy , surgery radiation therapy previous sample collection . Exclusion criterion control subject : Diagnosis asthma COPD . Broncheiactasis . Upper/lower respiratory tract infection precede 4 week . Active pulmonary tuberculosis Smoking group I .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>genetic signature</keyword>
	<keyword>non-small cell lung cancer</keyword>
	<keyword>micro RNA</keyword>
</DOC>